C07D 409/00
Heterocyclic compounds containing two or more hetero rings, at least one ring
Official title: Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
C07D409/00 (Heterocyclic compounds containing two or more hetero rings, at least one ring) appears on 14,896 US grants and 16,508 published applications in this corpus.
Search patents in C07D- Granted patents
- 14,896
- Published applications
- 16,508
- Assignees
- 3,663
- Inventors
- 35,874
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 32 | 0 |
| 1977 | 22 | 0 |
| 1978 | 17 | 0 |
| 1979 | 6 | 0 |
| 1980 | 8 | 0 |
| 1981 | 6 | 0 |
| 1982 | 9 | 0 |
| 1983 | 18 | 0 |
| 1984 | 41 | 0 |
| 1985 | 75 | 0 |
| 1986 | 71 | 0 |
| 1987 | 107 | 0 |
| 1988 | 127 | 0 |
| 1989 | 137 | 0 |
| 1990 | 151 | 0 |
| 1991 | 192 | 0 |
| 1992 | 187 | 0 |
| 1993 | 207 | 0 |
| 1994 | 166 | 0 |
| 1995 | 198 | 0 |
| 1996 | 212 | 0 |
| 1997 | 283 | 0 |
| 1998 | 286 | 0 |
| 1999 | 261 | 0 |
| 2000 | 292 | 0 |
| 2001 | 321 | 69 |
| 2002 | 382 | 354 |
| 2003 | 362 | 618 |
| 2004 | 316 | 838 |
| 2005 | 305 | 750 |
| 2006 | 417 | 719 |
| 2007 | 388 | 752 |
| 2008 | 416 | 667 |
| 2009 | 506 | 865 |
| 2010 | 567 | 854 |
| 2011 | 556 | 714 |
| 2012 | 584 | 630 |
| 2013 | 635 | 666 |
| 2014 | 646 | 719 |
| 2015 | 644 | 752 |
| 2016 | 540 | 678 |
| 2017 | 575 | 631 |
| 2018 | 512 | 580 |
| 2019 | 493 | 606 |
| 2020 | 469 | 669 |
| 2021 | 421 | 545 |
| 2022 | 369 | 577 |
| 2023 | 362 | 744 |
| 2024 | 350 | 596 |
| 2025 | 397 | 525 |
| 2026 | 252 | 390 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Aromatic amine derivative, and organic electroluminescent element using same6 Oct 2026US 12,753,145 B2Idemitsu Kosan Co., Ltd.
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof6 Oct 2026US 12,753,166 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- 1,5-disubstituted 1,2,3-triazoles are inhibitors of RAC/CDC42 GTPases6 Oct 2026US 12,753,183 B2University of Puerto Rico
- Organic light-emitting device and apparatus including the same6 Oct 2026US 12,757,632 B2Samsung Display Co., Ltd.
- Fluorine-free diarylethene photochromic compounds8 Oct 2026US 2026/0306382 A1School of Materials Science and Engineering, Nanyang Technological University
- Uric acid transporter agonist compound, pharmaceutical composition, and preparation method therefor and use thereof8 Oct 2026US 2026/0308136 A1Hangzhou E & J Biopharmaceutical Technology Co., Ltd.
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
- 5-ht2a receptor inverse agonist, and preparation method therefor and use thereof8 Oct 2026US 2026/0308142 A1Luye Innomind Pharma Shijiazhuang Co., Ltd.
- Targeting rnas associated with tauopathies with small molecules8 Oct 2026US 2026/0308158 A1University of Florida Research Foundation, Inc.
Most cited
By later US patents
- Pyrimidine derivatives and processes for the preparation thereof595US 5,521,184 ACiba-Geigy Corporation · 1996
- Methods for repairing damaged intervertebral discs571US 6,602,248 B1Arthro Care Corporation · 2003
- Methods for repairing damaged intervertebral discs418US 7,318,823 B2ArthroCare Corporation · 2008
- Cyclic-substituted unsymmetrical cyanine dyes371US 5,436,134 AMolecular Probes, Inc. · 1995
- Electron-conducting molecular preparations291US 5,556,524 AValtion Teknillinen Tutkimuskeskus · 1996